Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Crowley

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Annals of Surgical Oncology|December 8, 2017
STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In VitroAnna Aronova, Irene M Min, Michael J P Crowley, et al.
Annals of Surgical Oncology|May 24, 2014
Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumorsDavid A Kleiman, Toni Beninato, Samuel Sultan, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2016
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical CarcinomaMichael J P Crowley, Theresa Scognamiglio, Yi-Fang Liu, et al.
Nature Immunology|September 26, 2024
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1<sup>+</sup> progenitor CD8<sup>+</sup> T cells to improve immunotherapyGeoffrey J Markowitz, Yi Ban, Diamile A Tavarez, et al.
Research Square|October 4, 2023
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockadeGeoffrey J Markowitz, Yi Ban, Diamile A Tavarez, et al.
Nature Communications|January 9, 2023
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancerMichael J P Crowley, Bhavneet Bhinder, Geoffrey J Markowitz, et al.
Nature|October 12, 2018
IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activityMinkyung Song, Tito A Sandoval, Chang-Suk Chae, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Annals of Surgical Oncology|December 8, 2017
STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In VitroAnna Aronova, Irene M Min, Michael J P Crowley, et al.
Annals of Surgical Oncology|May 24, 2014
Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumorsDavid A Kleiman, Toni Beninato, Samuel Sultan, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2016
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical CarcinomaMichael J P Crowley, Theresa Scognamiglio, Yi-Fang Liu, et al.
Nature Immunology|September 26, 2024
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1<sup>+</sup> progenitor CD8<sup>+</sup> T cells to improve immunotherapyGeoffrey J Markowitz, Yi Ban, Diamile A Tavarez, et al.
Research Square|October 4, 2023
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve checkpoint blockadeGeoffrey J Markowitz, Yi Ban, Diamile A Tavarez, et al.
Nature Communications|January 9, 2023
Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancerMichael J P Crowley, Bhavneet Bhinder, Geoffrey J Markowitz, et al.
Nature|October 12, 2018
IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activityMinkyung Song, Tito A Sandoval, Chang-Suk Chae, et al.
Pageof 11